Rett Syndrome – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Rett Syndrome – Drugs In Development, 2024 report and make more profitable business decisions.
Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rapid destruction, Stage III or the plateau, and Stage IV or the late motor deterioration stage. Symptoms include slowed growth, loss of normal movement and coordination, loss of communication abilities, breathing problems, pain, irregular heartbeat, and seizures. Risk factors include family history and gender. Treatment includes disease modifying drugs.
The Rett Syndrome drugs in development market research report provide comprehensive information on the therapeutics under development for Rett Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rett Syndrome and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Rett Syndrome | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 55 molecules, with 54 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Rett Syndrome therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Rett Syndrome pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Rett Syndrome treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
1st Bio Therapeutics IncAcadia Pharmaceuticals Inc
Adge Pharmaceuticals Inc
Alcyone Therapeutics Inc
Amicus Therapeutics Inc
AMO Pharma Ltd
Ananda Scientific Inc
Anavex Life Sciences Corp
AriBio Co Ltd
ArmaGen Inc
Astellas Pharma Inc
Astrogen Ltd
Biomed Industries Inc
BioXcel Corp
Connecta Therapeutics SL
CuroNZ Ltd
DepYmed Inc
Echo Pharmaceuticals BV
Epeius Pharma Co
Epigen Biosciences Inc
EuMentis Therapeutics Inc
GEXVal Inc
Herophilus
Jazz Pharmaceuticals Plc
LizarBio Therapeutics Inc
Lucy Therapeutics Inc
Neuren Pharmaceuticals Ltd
Neurocores Inc
Neurogene Inc
Neurolixis Inc
Neurotech International Ltd
Novartis Gene Therapies
OrganAI AB
PharmaTher Holdings Ltd
PharmatrophiX Inc
Prilenia Therapeutics Development Ltd
Quiver Bioscience Inc
Rznomics Inc
Sarepta Therapeutics Inc
Shape Therapeutics Inc
Shenox Pharmaceuticals LLC
Starwise Therapeutics LLC
StrideBio Inc
Synaptogenix Inc
Thiogenesis Therapeutics Corp
Unravel Biosciences
Vaccinex Inc
Vanderbilt University
Vico Therapeutics BV
Vyant Bio Inc
Xosomix LLC
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Rett Syndrome reports